Bradley Esq - Anthera Pharmaceuticals Sec

Insider

Bradley Esq is Sec of Anthera Pharmaceuticals
Phone410 350 1839
Webhttps://www.anthera.com

Anthera Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of (1.4196) % which means that it has lost $1.4196 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.6885) %, meaning that it created substantial loss on money invested by shareholders. Anthera Pharmaceuticals' management efficiency ratios could be used to measure how well Anthera Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Kerry WhalenCullinan Oncology LLC
N/A
Edward DVMSAB Biotherapeutics
N/A
Adam ThomasSynlogic
N/A
John CPAUnicycive Therapeutics
63
Corinne SavillCullinan Oncology LLC
66
Judith MooreAC Immune
N/A
McKee MDGeoVax Labs
72
Carol WaldoCidara Therapeutics
N/A
Aidan CurranPulmatrix
N/A
Isabelle LefebvreEyepoint Pharmaceuticals
N/A
Marie KoscoVilboisAC Immune
66
MBA CMAPulmatrix
70
MBA MDCullinan Oncology LLC
51
Daniela SantiestebanSalarius Pharmaceuticals
N/A
Margaret MDPulmatrix
67
MPA MDUnicycive Therapeutics
52
Jay MDEyepoint Pharmaceuticals
66
David HavaSynlogic
49
Jennifer LeonardEyepoint Pharmaceuticals
N/A
Piergiorgio DonatiAC Immune
54
Joshua DrummAC Immune
N/A
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas. Anthera Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people. Anthera Pharmaceuticals [ANTH] is a Pink Sheet which is traded between brokers over the counter. Anthera Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Anthera Pharmaceuticals Leadership Team

Elected by the shareholders, the Anthera Pharmaceuticals' board of directors comprises two types of representatives: Anthera Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anthera. The board's role is to monitor Anthera Pharmaceuticals' management team and ensure that shareholders' interests are well served. Anthera Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anthera Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Bradley Esq, Sec
May Liu, Principal Accounting Officer, Compliance Officer and Sr. VP of Fin. and Admin.
Paul Adams, VP Compliance
Joshua Caldwell, Chief Officer
MBA MBA, Ex Chairman
Charles DSc, Advisor
Klara DickinsonEason, Advisor
John Thompson, CEO Director

Anthera Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anthera Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Anthera Pink Sheet

If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm